121 related articles for article (PubMed ID: 35840111)
1. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
[TBL] [Abstract][Full Text] [Related]
2. Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.
Dorling L; Barnett GC; Michailidou K; Coles CE; Burnet NG; Yarnold J; Elliott RM; Dunning AM; Pharoah PD; West CM
Clin Cancer Res; 2016 Mar; 22(6):1413-20. PubMed ID: 26510858
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
Ahmed M; Dorling L; Kerns S; Fachal L; Elliott R; Partliament M; Rosenstein BS; Vega A; Gómez-Caamaño A; Barnett G; Dearnaley DP; Hall E; Sydes M; Burnet N; Pharoah PD; Eeles R; West CM
Br J Cancer; 2016 May; 114(10):1165-74. PubMed ID: 27070714
[TBL] [Abstract][Full Text] [Related]
4. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
[TBL] [Abstract][Full Text] [Related]
5. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
Seibold P; Behrens S; Schmezer P; Helmbold I; Barnett G; Coles C; Yarnold J; Talbot CJ; Imai T; Azria D; Koch CA; Dunning AM; Burnet N; Bliss JM; Symonds RP; Rattay T; Suga T; Kerns SL; Bourgier C; Vallis KA; Sautter-Bihl ML; Claßen J; Debus J; Schnabel T; Rosenstein BS; Wenz F; West CM; Popanda O; Chang-Claude J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1084-1092. PubMed ID: 26072091
[TBL] [Abstract][Full Text] [Related]
6. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
8. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
11. Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach.
Lee E; Eum SY; Slifer SH; Martin ER; Takita C; Wright JL; Hines RB; Hu JJ
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):948-957. PubMed ID: 32007367
[TBL] [Abstract][Full Text] [Related]
12. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Lecarpentier J; Silvestri V; Kuchenbaecker KB; Barrowdale D; Dennis J; McGuffog L; Soucy P; Leslie G; Rizzolo P; Navazio AS; Valentini V; Zelli V; Lee A; Amin Al Olama A; Tyrer JP; Southey M; John EM; Conner TA; Goldgar DE; Buys SS; Janavicius R; Steele L; Ding YC; Neuhausen SL; Hansen TVO; Osorio A; Weitzel JN; Toss A; Medici V; Cortesi L; Zanna I; Palli D; Radice P; Manoukian S; Peissel B; Azzollini J; Viel A; Cini G; Damante G; Tommasi S; Peterlongo P; Fostira F; Hamann U; Evans DG; Henderson A; Brewer C; Eccles D; Cook J; Ong KR; Walker L; Side LE; Porteous ME; Davidson R; Hodgson S; Frost D; Adlard J; Izatt L; Eeles R; Ellis S; Tischkowitz M; ; Godwin AK; Meindl A; Gehrig A; Dworniczak B; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Hauke J; Rhiem K; Kast K; Arnold N; Ditsch N; Wang-Gohrke S; Wappenschmidt B; Wand D; Lasset C; Stoppa-Lyonnet D; Belotti M; Damiola F; Barjhoux L; Mazoyer S; ; Van Heetvelde M; Poppe B; De Leeneer K; Claes KBM; de la Hoya M; Garcia-Barberan V; Caldes T; Perez Segura P; Kiiski JI; Aittomäki K; Khan S; Nevanlinna H; van Asperen CJ; ; Vaszko T; Kasler M; Olah E; Balmaña J; Gutiérrez-Enríquez S; Diez O; Teulé A; Izquierdo A; Darder E; Brunet J; Del Valle J; Feliubadalo L; Pujana MA; Lazaro C; Arason A; Agnarsson BA; Johannsson OT; Barkardottir RB; Alducci E; Tognazzo S; Montagna M; Teixeira MR; Pinto P; Spurdle AB; Holland H; ; Lee JW; Lee MH; Lee J; Kim SW; Kang E; Kim Z; Sharma P; Rebbeck TR; Vijai J; Robson M; Lincoln A; Musinsky J; Gaddam P; Tan YY; Berger A; Singer CF; Loud JT; Greene MH; Mulligan AM; Glendon G; Andrulis IL; Toland AE; Senter L; Bojesen A; Nielsen HR; Skytte AB; Sunde L; Jensen UB; Pedersen IS; Krogh L; Kruse TA; Caligo MA; Yoon SY; Teo SH; von Wachenfeldt A; Huo D; Nielsen SM; Olopade OI; Nathanson KL; Domchek SM; Lorenchick C; Jankowitz RC; Campbell I; James P; Mitchell G; Orr N; Park SK; Thomassen M; Offit K; Couch FJ; Simard J; Easton DF; Chenevix-Trench G; Schmutzler RK; Antoniou AC; Ottini L
J Clin Oncol; 2017 Jul; 35(20):2240-2250. PubMed ID: 28448241
[TBL] [Abstract][Full Text] [Related]
14. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Franco NR; Massi MC; Ieva F; Manzoni A; Paganoni AM; Zunino P; Veldeman L; Ost P; Fonteyne V; Talbot CJ; Rattay T; Webb A; Johnson K; Lambrecht M; Haustermans K; De Meerleer G; de Ruysscher D; Vanneste B; Van Limbergen E; Choudhury A; Elliott RM; Sperk E; Veldwijk MR; Herskind C; Avuzzi B; Noris Chiorda B; Valdagni R; Azria D; Farcy-Jacquet MP; Brengues M; Rosenstein BS; Stock RG; Vega A; Aguado-Barrera ME; Sosa-Fajardo P; Dunning AM; Fachal L; Kerns SL; Payne D; Chang-Claude J; Seibold P; West CML; Rancati T;
Radiother Oncol; 2021 Jun; 159():241-248. PubMed ID: 33838170
[TBL] [Abstract][Full Text] [Related]
15. Validation of a prostate cancer polygenic risk score.
Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
[TBL] [Abstract][Full Text] [Related]
16. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer.
Kerns SL; Amidon Morlang A; Lee SM; Peterson DR; Marples B; Zhang H; Bylund K; Rosenzweig D; Hall W; De Ruyck K; Rosenstein BS; Stock RG; Gómez-Caamaño A; Vega A; Sosa-Fajardo P; Taboada-Valladares B; Aguado-Barrera ME; Parker C; Veldeman L; Fonteyne V; Bultijnck R; Talbot CJ; Symonds RP; Johnson K; Rattay T; Webb A; Lambrecht M; de Ruysscher D; Vanneste B; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Rancati T; Avuzzi B; Valdagni R; Azria D; Farcy Jacquet MP; Chang-Claude J; Seibold P; West C; Janelsins M; Chen Y; Messing E; Morrow G;
Radiother Oncol; 2022 Mar; 168():75-82. PubMed ID: 35077710
[TBL] [Abstract][Full Text] [Related]
17. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
Seibold P; Webb A; Aguado-Barrera ME; Azria D; Bourgier C; Brengues M; Briers E; Bultijnck R; Calvo-Crespo P; Carballo A; Choudhury A; Cicchetti A; Claßen J; Delmastro E; Dunning AM; Elliott RM; Fachal L; Farcy-Jacquet MP; Gabriele P; Garibaldi E; Gómez-Caamaño A; Gutiérrez-Enríquez S; Higginson DS; Johnson K; Lobato-Busto R; Mollà M; Müller A; Payne D; Peleteiro P; Post G; Rancati T; Rattay T; Reyes V; Rosenstein BS; De Ruysscher D; De Santis MC; Schäfer J; Schnabel T; Sperk E; Symonds RP; Stobart H; Taboada-Valladares B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Ward T; Weißenberger C; West CML; Chang-Claude J;
Radiother Oncol; 2019 Sep; 138():59-67. PubMed ID: 31146072
[TBL] [Abstract][Full Text] [Related]
18. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
Shieh Y; Fejerman L; Lott PC; Marker K; Sawyer SD; Hu D; Huntsman S; Torres J; Echeverry M; Bohórquez ME; Martínez-Chéquer JC; Polanco-Echeverry G; Estrada-Flórez AP; ; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Vidaurre T; Weitzel JN; Zambrano SC; Carvajal-Carmona LG; Ziv E; Neuhausen SL
J Natl Cancer Inst; 2020 Jun; 112(6):590-598. PubMed ID: 31553449
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving Radiotherapy.
Córdoba EE; Abba MC; Lacunza E; Fernánde E; Güerci AM
Cancer Res Treat; 2016 Jul; 48(3):948-54. PubMed ID: 26790968
[TBL] [Abstract][Full Text] [Related]
20. Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
